Pet Pharm Biotech Overview
- Year Founded
-
2011
- Status
-
IPO Registration
- Employees
-
44
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
3
Pet Pharm Biotech General Information
Description
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
Contact Information
Website
www.petpharmbio.comCorporate Office
- 6F, No. 296, Jianguo 1st Road
- Xinzhuang District
- New Taipei
- Taiwan
Corporate Office
- 6F, No. 296, Jianguo 1st Road
- Xinzhuang District
- New Taipei
- Taiwan
Pet Pharm Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. IPO | 23-Sep-2025 | Announced | Profitable | |||
| 1. Later Stage VC | Completed | Startup |
Pet Pharm Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pet Pharm Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BqSv | Corporation | Minority | ||
| First Financial Holding | Corporation | Minority | ||
| SinoPac Financial Holdings | Holding Company | Minority |
Pet Pharm Biotech Acquisitions (1)
Pet Pharm Biotech’s most recent deal was a Merger/Acquisition with ELEM Biotech. The deal was made on 29-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ELEM Biotech | 29-Oct-2026 | Merger/Acquisition | Discovery Tools (Healthcare) |
Pet Pharm Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Pet Pharm Biotech Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| ELEM Biotech | Wuhan, China | 2018 |
Pet Pharm Biotech FAQs
-
When was Pet Pharm Biotech founded?
Pet Pharm Biotech was founded in 2011.
-
Where is Pet Pharm Biotech headquartered?
Pet Pharm Biotech is headquartered in New Taipei, Taiwan.
-
What is the size of Pet Pharm Biotech?
Pet Pharm Biotech has 44 total employees.
-
What industry is Pet Pharm Biotech in?
Pet Pharm Biotech’s primary industry is Pharmaceuticals.
-
Is Pet Pharm Biotech a private or public company?
Pet Pharm Biotech is a Private company.
-
What is Pet Pharm Biotech’s current revenue?
The current revenue for Pet Pharm Biotech is .
-
Who are Pet Pharm Biotech’s investors?
BqSv, First Financial Holding, and SinoPac Financial Holdings have invested in Pet Pharm Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
